Cargando…

MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate

Soy glycinin (11S) is involved in immune regulation. As an additive, sodium butyrate (SB) can relieve inflammation caused by 11S. To further delve into the mechanisms. A diet containing 50% fishmeal was the control group (FM group), and the experimental groups consisted of the FM group baseline plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Bin, Liu, Hongyu, Tan, Beiping, Dong, Xiaohui, Chi, Shuyan, Yang, Qihui, Zhang, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849651/
https://www.ncbi.nlm.nih.gov/pubmed/33537033
http://dx.doi.org/10.3389/fimmu.2020.615980
_version_ 1783645345255784448
author Yin, Bin
Liu, Hongyu
Tan, Beiping
Dong, Xiaohui
Chi, Shuyan
Yang, Qihui
Zhang, Shuang
author_facet Yin, Bin
Liu, Hongyu
Tan, Beiping
Dong, Xiaohui
Chi, Shuyan
Yang, Qihui
Zhang, Shuang
author_sort Yin, Bin
collection PubMed
description Soy glycinin (11S) is involved in immune regulation. As an additive, sodium butyrate (SB) can relieve inflammation caused by 11S. To further delve into the mechanisms. A diet containing 50% fishmeal was the control group (FM group), and the experimental groups consisted of the FM group baseline plus 2% glycinin (GL group), 8% glycinin (GH group), and 8% glycinin + 0.13% sodium butyrate (GH-SB group). The specific growth ratio (SGR), feed utilization, and density of distal intestinal (DI) type II mucous cells were increased in the GL group. In the serum, IFN-γ was significantly upregulated in the GL group, and IgG and IL-1β were upregulated in the GH group. IgG, IL-1β, and TNF-α in the GH-SB group were significantly downregulated compared to those in the GH group. The mRNA levels of mTOR C1, mTOR C2, and Deptor were upregulated in the GL, GH, and GH-SB groups in the DI compared with those in the FM group, while the mRNA levels of mTOR C1 and Deptor in the GH group were higher than those in the GL and GH-SB groups. 4E-BP1, RICTOR, PRR5, MHC II, and CD4 were upregulated in the GH group. TSC1, mLST8, and NFY mRNA levels in the GL and GH-SB groups were upregulated compared with those in the FM and GH groups. Western blotting showed P-PI(3)K(Ser294)/T-PI(3)K, P-Akt(Ser473)/T-Akt, and P-mTOR(Ser2448)/T-mTOR were upregulated in the GH group. Collectively, our results demonstrate that low-dose 11S could improve serum immune by secreting IFN-γ. The overexpression of IgG and IL-1β is the reason that high-dose 11S reduces serum immune function, and supplementing SB can suppress this overexpression. Low-dose 11S can block the relationship between PI(3)K and mTOR C2. It can also inhibit the expression of 4E-BP1 through mTOR C1. High-dose 11S upregulates 4E-BP2 through mTOR C1, aggravating intestinal inflammation. SB could relieve inflammation by blocking PI(3)K/mTOR C2 and inhibiting 4E-BP2. Generally speaking, the hybrid grouper obtained different serum and DI immune responses under different doses of 11S, and these responses were ultimately manifested in growth performance. SB can effectively enhance serum immunity and relieve intestinal inflammation caused by high dose 11S.
format Online
Article
Text
id pubmed-7849651
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78496512021-02-02 MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate Yin, Bin Liu, Hongyu Tan, Beiping Dong, Xiaohui Chi, Shuyan Yang, Qihui Zhang, Shuang Front Immunol Immunology Soy glycinin (11S) is involved in immune regulation. As an additive, sodium butyrate (SB) can relieve inflammation caused by 11S. To further delve into the mechanisms. A diet containing 50% fishmeal was the control group (FM group), and the experimental groups consisted of the FM group baseline plus 2% glycinin (GL group), 8% glycinin (GH group), and 8% glycinin + 0.13% sodium butyrate (GH-SB group). The specific growth ratio (SGR), feed utilization, and density of distal intestinal (DI) type II mucous cells were increased in the GL group. In the serum, IFN-γ was significantly upregulated in the GL group, and IgG and IL-1β were upregulated in the GH group. IgG, IL-1β, and TNF-α in the GH-SB group were significantly downregulated compared to those in the GH group. The mRNA levels of mTOR C1, mTOR C2, and Deptor were upregulated in the GL, GH, and GH-SB groups in the DI compared with those in the FM group, while the mRNA levels of mTOR C1 and Deptor in the GH group were higher than those in the GL and GH-SB groups. 4E-BP1, RICTOR, PRR5, MHC II, and CD4 were upregulated in the GH group. TSC1, mLST8, and NFY mRNA levels in the GL and GH-SB groups were upregulated compared with those in the FM and GH groups. Western blotting showed P-PI(3)K(Ser294)/T-PI(3)K, P-Akt(Ser473)/T-Akt, and P-mTOR(Ser2448)/T-mTOR were upregulated in the GH group. Collectively, our results demonstrate that low-dose 11S could improve serum immune by secreting IFN-γ. The overexpression of IgG and IL-1β is the reason that high-dose 11S reduces serum immune function, and supplementing SB can suppress this overexpression. Low-dose 11S can block the relationship between PI(3)K and mTOR C2. It can also inhibit the expression of 4E-BP1 through mTOR C1. High-dose 11S upregulates 4E-BP2 through mTOR C1, aggravating intestinal inflammation. SB could relieve inflammation by blocking PI(3)K/mTOR C2 and inhibiting 4E-BP2. Generally speaking, the hybrid grouper obtained different serum and DI immune responses under different doses of 11S, and these responses were ultimately manifested in growth performance. SB can effectively enhance serum immunity and relieve intestinal inflammation caused by high dose 11S. Frontiers Media S.A. 2021-01-18 /pmc/articles/PMC7849651/ /pubmed/33537033 http://dx.doi.org/10.3389/fimmu.2020.615980 Text en Copyright © 2021 Yin, Liu, Tan, Dong, Chi, Yang and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yin, Bin
Liu, Hongyu
Tan, Beiping
Dong, Xiaohui
Chi, Shuyan
Yang, Qihui
Zhang, Shuang
MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate
title MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate
title_full MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate
title_fullStr MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate
title_full_unstemmed MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate
title_short MHC II-PI(3)K/Akt/mTOR Signaling Pathway Regulates Intestinal Immune Response Induced by Soy Glycinin in Hybrid Grouper: Protective Effects of Sodium Butyrate
title_sort mhc ii-pi(3)k/akt/mtor signaling pathway regulates intestinal immune response induced by soy glycinin in hybrid grouper: protective effects of sodium butyrate
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849651/
https://www.ncbi.nlm.nih.gov/pubmed/33537033
http://dx.doi.org/10.3389/fimmu.2020.615980
work_keys_str_mv AT yinbin mhciipi3kaktmtorsignalingpathwayregulatesintestinalimmuneresponseinducedbysoyglycinininhybridgrouperprotectiveeffectsofsodiumbutyrate
AT liuhongyu mhciipi3kaktmtorsignalingpathwayregulatesintestinalimmuneresponseinducedbysoyglycinininhybridgrouperprotectiveeffectsofsodiumbutyrate
AT tanbeiping mhciipi3kaktmtorsignalingpathwayregulatesintestinalimmuneresponseinducedbysoyglycinininhybridgrouperprotectiveeffectsofsodiumbutyrate
AT dongxiaohui mhciipi3kaktmtorsignalingpathwayregulatesintestinalimmuneresponseinducedbysoyglycinininhybridgrouperprotectiveeffectsofsodiumbutyrate
AT chishuyan mhciipi3kaktmtorsignalingpathwayregulatesintestinalimmuneresponseinducedbysoyglycinininhybridgrouperprotectiveeffectsofsodiumbutyrate
AT yangqihui mhciipi3kaktmtorsignalingpathwayregulatesintestinalimmuneresponseinducedbysoyglycinininhybridgrouperprotectiveeffectsofsodiumbutyrate
AT zhangshuang mhciipi3kaktmtorsignalingpathwayregulatesintestinalimmuneresponseinducedbysoyglycinininhybridgrouperprotectiveeffectsofsodiumbutyrate